UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000039199
Receipt No. R000044702
Scientific Title Examination on change of gastric emptying ability by acid secretion suppression
Date of disclosure of the study information 2020/01/20
Last modified on 2021/06/23 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Examination on change of gastric emptying ability by acid secretion suppression
Acronym Examination on change of gastric emptying ability by acid secretion suppression
Scientific Title Examination on change of gastric emptying ability by acid secretion suppression
Scientific Title:Acronym Examination on change of gastric emptying ability by acid secretion suppression
Region
Japan

Condition
Condition Reflux Esophagitis
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study of aim is to confirm the influence for gastric emptying by the gastric acid secretion.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Determine how gastric emptying is related to gastric emptying by measuring gastric emptying using the 13C breath test gastric emptying test.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine Other
Interventions/Control_1 Vonoprazan is available in 10mg and 20mg formulations, each for 2 weeks. 13C Breath test Gastric emptying test is performed before, after taking 10 mg and after taking 20 mg of vonoprazan.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >
Gender Male and Female
Key inclusion criteria Healthy volunteers
Key exclusion criteria Persons who do not fit the above
Target sample size 10

Research contact person
Name of lead principal investigator
1st name Kazuhide
Middle name
Last name Higuchi
Organization Osaka medical college
Division name Second department of internal medicine
Zip code 569-8686
Address 2-7, Daigaku-machi, Takatsuki
TEL 072-683-1221
Email higuchi@osaka-med.ac.jp

Public contact
Name of contact person
1st name Kazuhiro
Middle name
Last name Ota
Organization Osaka medical college
Division name Second department of internal medicine
Zip code 569-8686
Address 2-7, Daigaku-machi, Takatsuki
TEL 072-683-1221
Homepage URL
Email clash_kaz@yathoo.co.jp

Sponsor
Institute Osaka medical college
Institute
Department

Funding Source
Organization Self-funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ethic review committee at osaka medical college
Address 2-7, Daigaku-machi, Takatsuki
Tel 072-683-1221
Email omc_rinsyou@osaka-med.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 01 Month 20 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled 10
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2020 Year 01 Month 18 Day
Date of IRB
2020 Year 01 Month 18 Day
Anticipated trial start date
2020 Year 01 Month 19 Day
Last follow-up date
2020 Year 07 Month 20 Day
Date of closure to data entry
2020 Year 07 Month 20 Day
Date trial data considered complete
2020 Year 07 Month 20 Day
Date analysis concluded
2020 Year 07 Month 21 Day

Other
Other related information

Management information
Registered date
2020 Year 01 Month 19 Day
Last modified on
2021 Year 06 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044702